Trial intelligence / Profile preview

Cardiovascular effects of tamsulosin and sildenafil in BPH patients

2005-000660-74Phase 4Completed

Sponsor
Tuomo Nieminen
Start
Feb 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tamsulosin and sildenafil in benign prostatic hyperplasia (BPH) (3 arms), sponsored by Tuomo Nieminen. Primary endpoints: Hemodynamic responses at rest and Hemodynamic responses during tilt-table test. Started Feb 2005; status: completed.

02

Drugs

tamsulosinsildenafil
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on 2005-000660-74.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000660-74.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call